Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

Xing Guo, M.MD, Donghua He, PhD, Jing Chen, M.MD, Xuanru Lin, M.MD, Qingxiao Chen, M.MD, Haimeng Yan, Xi Huang, M.MD, Yi Li, PhD, Li Yang, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 2086.

https://doi.org/10.1182/blood.V128.22.2086.2086

Published: 2016

Journal Articles

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Jing Chen, M.MD, Donghua He, PhD, Xing Guo, M.MD, Qingxiao Chen, M.MD, Xuanru Lin, M.MD, Jingsong He, Xi Huang, M.MD, Haimeng Yan, Yi Li, PhD, Li Yang, PhD, Yang Yang, PhD, Enfan Zhang, M.MD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 4429.

https://doi.org/10.1182/blood.V128.22.4429.4429

Published: 2016

Journal Articles

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Qingxiao Chen, M.MD, Jingsong He, PhD, Xing Guo, M.MD, Jing Chen, M.MD, Li Yang, PhD, Xuanru Lin, M.MD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, Wenjun Wu, MD, Donghua He, PhD, He Huang, MD PhD, Shizhou Liu, MD PhD, Zhen Cai, MD PhD

Blood (2015) 126 (23): 3643.

https://doi.org/10.1182/blood.V126.23.3643.3643

Published: 2015

Journal Articles

Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study.

Wenjun Wu, MD, Gaofeng Zheng, MD, Xiaoyan Han, MD, Yi Zhao, PhD, Donghua He, PhD, Yang Yang, PhD, Jingsong He, PhD, Weiyan Zheng, Jie Sun, MD PhD, Jimin Shi, Guoqing Wei, MD PhD, He Huang, MD PhD, Zhen Cai

Blood (2015) 126 (23): 5387.

https://doi.org/10.1182/blood.V126.23.5387.5387

Published: 2015

Journal Articles

Quercetin Displays Anti-Myeloma Activity and Synergistic Effect with Dexamethasone in Vitro and In Vivo Xenograft Models

Xing Guo, M.MD, Donghua He, PhD, Li Yang, PhD, Yi Li, PhD, Qingxiao Chen, M.MD, Jing Chen, M.MD, Enfan Zhang, M.MD, Xuanru Lin, M.MD, Jingsong He, PhD, Yang Yang, PhD, Xiaoyan Han, MD, Gaofeng Zheng, MD, Wenjun Wu, MD, Yi Zhao, PhD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2015) 126 (23): 5339.

https://doi.org/10.1182/blood.V126.23.5339.5339

Published: 2015

Journal Articles

Bortezomib-Resistance Is Characterized By Upregulation of E3 Ligase Pirh2 Which Protects Bortezomib Induced Apoptosis in Multiple Myeloma Cells

Li Yang, M.MD, Jingsong He, Yi Li, M.MD, Xing Guo, M.MD, Jing Chen, M.MD, Qingxiao Chen, M.MD, Xuanru Lin, M.MD, Donghua He, PhD, Yang Yang, PhD, Enfan Zhang, M.MD, Xiaoyan Han, M.MD, Wenjun Wu, M.MD, Yi Zhao, PhD, Gaofeng Zheng, M.MD, He Huang, MDPhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 3391.

https://doi.org/10.1182/blood.V124.21.3391.3391

Published: 2014

Journal Articles

The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma

Jing Chen, M.MD, Donghua He, PhD, Xing Guo, M.MD, Li Yang, M.MD, Yi Li, M.MD, Qingxiao Chen, M.MD, Jingsong He, Yang Yang, PhD, Enfan Zhang, M.MD, WenJun Wu, Xiaoyan Han, M.MD, Gaofeng Zheng, M.MD, Yi Zhao, PhD, He Huang, MDPhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 5701.

https://doi.org/10.1182/blood.V124.21.5701.5701

Published: 2014

Journal Articles

Targeting HMGB1 Increased the Sensitivity of MM Cells to Chemotherapy

Xing Guo, M.MD, Donghua He, PhD, Jing Chen, M.MD, Li Yang, M.MD, Yi Li, M.MD, Qingxiao Chen, M.MD, Jingsong He, Yang Yang, PhD, Enfan Zhang, M.MD, Wenjun Wu, M.MD, Xiaoyan Han, M.MD, Gaofeng Zheng, M.MD, Yi Zhao, PhD, He Huang, MDPhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 5703.

https://doi.org/10.1182/blood.V124.21.5703.5703

Published: 2014

Journal Articles

Oxymatrine Induces Apoptosis in Human Myeloma Cells By Cell Cycle Arrest and Activation of Caspase-Dependent Apoptosis

Wenjun Wu, M.MD, Cai Wu, M.MD, Fuming Zi, PhD, Yi Li, MD, Li Yang, M.MD, Jingsong He, PhD, Donghua He, PhD, Yang Yang, PhD, Yi Zhao, PhD, Xiaoyan Han, M.MD, Gaofeng Zheng, M.MD, He Huang, MDPhD, Zhen Cai, MD PhD

Blood (2014) 124 (21): 5727.

https://doi.org/10.1182/blood.V124.21.5727.5727

Published: 2014

Journal Articles

The Expression Of CD200 As a Prognostic Factor In Newly Diagnosed Multiple Myeloma

Yi Li, M.Med, Wenjun Wu, M.Med, Jingsong He, MD, PhD, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Fuming Zi, M.Med, Li Yang, M.Med, Cai Wu, M.Med, Donghua He, PhD, Yi Zhao, PhD, Yang Yang, PhD, Lijuan Wang, PhD, Xiujin Ye, M.D. Ph.D., He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD

Blood (2013) 122 (21): 3082.

https://doi.org/10.1182/blood.V122.21.3082.3082

Published: 2013

Journal Articles

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Fuming Zi, M.Med, Jingsong He, MD, PhD, Donghua He, PhD, Yi Li, M.Med, Li Yang, M.Med, Lijuan Wang, PhD, Yang Yang, PhD, Yi Zhao, PhD, Wenjun Wu, M.Med, He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD

Blood (2013) 122 (21): 3083.

https://doi.org/10.1182/blood.V122.21.3083.3083

Published: 2013

Journal Articles

Rab7b Promotes Megakaryocytic Differentiation of K562 Cells by Activating the Protein Kinase C/Extracellular Signal-Regulated Kinase Dependent Pathway.

Donghua He, PhD, Taoyong Chen, Mingjin Yang, Chaofeng Han, Yang Yang, PhD, Xuetao Cao, Zhen Cai, MD, PhD

Blood (2009) 114 (22): 3612.

https://doi.org/10.1182/blood.V114.22.3612.3612

Published: 2009

Journal Articles

Triggering of Toll-Like Receptor 4 Expression in Human Multiple Myeloma Promotes Proliferation and Protects the Cells From Immune and Chemotherapy Drug Attack.

Zhen Cai, Hanying Bao, Lijuan Wang, PhD, Yang Yang, PhD, Yi Zhao, PhD, Donghua He, PhD, Peilin Lu, MD, PhD, Michael Wang, M.D.

Blood (2009) 114 (22): 2843.

https://doi.org/10.1182/blood.V114.22.2843.2843

Published: 2009

NARROW

Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study.

Quercetin Displays Anti-Myeloma Activity and Synergistic Effect with Dexamethasone in Vitro and In Vivo Xenograft Models

Bortezomib-Resistance Is Characterized By Upregulation of E3 Ligase Pirh2 Which Protects Bortezomib Induced Apoptosis in Multiple Myeloma Cells

The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma

Targeting HMGB1 Increased the Sensitivity of MM Cells to Chemotherapy

Oxymatrine Induces Apoptosis in Human Myeloma Cells By Cell Cycle Arrest and Activation of Caspase-Dependent Apoptosis

The Expression Of CD200 As a Prognostic Factor In Newly Diagnosed Multiple Myeloma

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Rab7b Promotes Megakaryocytic Differentiation of K562 Cells by Activating the Protein Kinase C/Extracellular Signal-Regulated Kinase Dependent Pathway.

Triggering of Toll-Like Receptor 4 Expression in Human Multiple Myeloma Promotes Proliferation and Protects the Cells From Immune and Chemotherapy Drug Attack.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only